In line with our findings, others have shown high CCL11 levels in conditions that are characterized by pathological bone loss, e.g., RA (8), osteoarthritis (9), and osteoporosis (10), strongly suggesting that CCL11 plays a decisive role in inflammation-induced bone resorption. This evidence concerns the gene CCL11 and rheumatoid arthritis.